Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05712018
Status:
COMPLETED
Last Update Posted:
2024-02-02
First Post:
2023-01-10
Brief Title:
Comparison of Different HES Coload Volumes on the 90 ED of Norepinephrine
Sponsor:
General Hospital of Ningxia Medical University
Organization:
General Hospital of Ningxia Medical University
Study Overview
Official Title:
Comparison of Different 6 Hydroxyethyl Starch 13004 Coload Volumes on the 90 Effective Dose of Norepinephrine Infusion Prophylaxis for Hypotension During Spinal Anesthesia for Cesarean Section
Status:
COMPLETED
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate the effect of different 6 hydroxyethyl starch 13004 coload volumes on the 90 effective dose of norepinephrine infusion prophylaxis for hypotension during spinal anesthesia for cesarean section
Detailed Description:
Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section The incidence of post-spinal anesthesia hypotension is as high as 621-897 if prophylactic measures are not taken Coload has been highly demonstrated for prevention andor treatment of post-spinal anesthesia hypotension In addition theres some evidence that prophylactic infusion of norepinephrine could effectively reduce the incidence of post-spinal anesthesia hypotension in parturients undergoing cesarean section The purpose of this study is to investigate the effect of different 6 hydroxyethyl starch 13004 coload volumes on the 90 effective dose of norepinephrine infusion prophylaxis for hypotension during spinal anesthesia for cesarean section
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None